JOSHUA FEINBERG: Open Payments
NPI 1326212606 · BROOMALL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 51 payments from 21 companies in 2025. Trend: 2023 $1,873 · 2024 $2,930 · 2025 $970
Food & beverage: $970
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $140 |
| ABBVIE INC. | 8 | $139 |
| PFIZER INC. | 6 | $121 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| Intra-Sana Laboratories | 2 | $45 |
| Optinose US, Inc. | 2 | $41 |
| Bausch Health US, LLC | 2 | $39 |
| Abbott Laboratories | 2 | $39 |
Products named: Wegovy, QULIPTA, VRAYLAR, TRELEGY ELLIPTA, JARDIANCE, Ozempic, RELTONE 200 MG, Xhance.
Industry payments across PA — which companies pay providers there.
